Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
A rare condition, HAE, causes unpredictable swelling attacks that can be life-threatening. Day-to-day, patients live with the…
A high school senior, Jack recalls more than a decade of swelling attacks due to hereditary angioedema, including a life-thre…
Lexi lives with the rare disease hereditary angioedema (HAE). She reflects on how the condition’s random swelling attacks imp…
The U.S. Hereditary Angioedema Association (HAEA) and HAE International (HAEi) offer fun, educational and empowering programm…
To better understand how patients experience hereditary angioedema (HAE), CSL invited Anthony Castaldo and Henrik Boysen to m…
Test your knowledge of hereditary angioedema, a rare disease that causes unpredictable swelling.
The March 15-17 event offers a hybrid learning opportunity for doctors and other health care providers who want a deep dive i…
Video: Cheryl describes her journey coping with the rare disease hereditary angioedema (HAE) and how it has impacted her fami…
Research found slightly more than half of HAE patients who had COVID-19 experienced a swelling attack while infected.
A recent survey shed light on how this rare disease affects daily life and what they value most.
Hereditary angioedema, a challenging rare disease to manage, causes serious swelling episodes. Children can have them, too.
CSL Behring made three recent announcements related to medicines known as “mabs.”
Americas
Asia Pacific
Middle East
Europe
